Cohance Lifesciences Limited (NSE:COHANCE)

Cohance Lifesciences Revenue

Cohance Lifesciences had revenue of 5.63B INR in the quarter ending June 30, 2025, with 144.26% growth. This brings the company's revenue in the last twelve months to 12.54B, up 34.14% year-over-year. In the fiscal year ending March 31, 2025, Cohance Lifesciences had annual revenue of 11.98B with 13.91% growth.

• Revenue (ttm): 12.54B
• Revenue Growth: +34.14%
• P/S Ratio: 27.89
• Revenue / Employee: 10.51M
• Employees: 1,193
• Market Cap: 349.61B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	11.98B	1.46B	13.91%
Mar 31, 2024	10.51B	-2.89B	-21.56%
Mar 31, 2023	13.40B	201.07M	1.52%
Mar 31, 2022	13.20B	3.11B	30.75%
Mar 31, 2021	10.10B	1.76B	21.10%